List of works - Sofia Agelaki

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer

scientific article published on 20 November 2017

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer ⬇️

scientific article published on November 11, 2010

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer

scientific article

A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer

scientific article

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

scientific article

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer

scientific article published on 22 January 2009

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

scientific article published on 01 February 2013

A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer

scientific article published on 14 October 2011

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer ⬇️

scientific article published on November 19, 2010

A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer

scientific article published in July 2006

Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells

scientific article published on January 2007

Apoptotic circulating tumor cells in early and metastatic breast cancer patients

scientific article published on 18 June 2013

BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

scientific article published on 05 February 2020

Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges

scientific article published on 8 June 2016

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer

Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

scientific article published on 11 July 2018

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

scientific article

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer

scientific article published on 06 November 2018

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

scientific article published on 06 February 2020

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

scientific article

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

scientific article

Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice

scientific article

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

scientific article published on 30 March 2009

Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer

scientific article published on 20 November 2020

Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer

scientific article published on 02 June 2014

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

scientific article

Detection of the T cell activation state using non-linear optical microscopy

article

Distinction between breast cancer cell subtypes using third harmonic generation microscopy

scientific article

ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.

scientific article

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

scientific article published on 17 June 2015

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib

scientific article published on 4 February 2014

Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer

scientific article published in November 2005

Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.

scientific article

Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes.

scientific article published on 2 August 2017

Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.

scientific article published on 19 August 2015

Fatal Nocardia farcinica bacteremia in a patient with lung cancer

scientific article published in October 2004

Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

scientific article (publication date: 30 May 2007)

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

scientific article

Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises

scientific article published on 03 February 2020

Non-platinum-based first-line followed by platinum-based second-line chemotherapy or the reverse sequence in patients with advanced non-small cell lung cancer: a retrospective analysis by the lung cancer group of the Hellenic Oncology Research Group

scientific article published on 04 June 2010

Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors

scientific article published on September 2002

Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy

scientific article published on 12 June 2020

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study

scientific article

Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors

scientific article published in June 2005

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients.

scientific article published on 24 December 2016

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

scientific article published on 29 September 2008

Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.

scientific article published on 22 June 2017

Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect

scientific article published on 28 December 2010

Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

scientific article published on 19 December 2018

Third Harmonic Generation microscopy distinguishes malignant cell grade in human breast tissue biopsies

scientific article published on 06 July 2020

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer

scientific article published on 13 May 2015

List of works by Sofia Agelaki

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer ⬇️

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer

A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer ⬇️

A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer

Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells

Apoptotic circulating tumor cells in early and metastatic breast cancer patients

BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects

Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer

Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

Detection of KRAS G12/G13 Mutations in Cell Free-DNA by Droplet Digital PCR, Offers Prognostic Information for Patients with Advanced Non-Small Cell Lung Cancer

Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

Detection of the T cell activation state using non-linear optical microscopy

Distinction between breast cancer cell subtypes using third harmonic generation microscopy

ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib

Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer

Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.

Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes.

Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.

Fatal Nocardia farcinica bacteremia in a patient with lung cancer

Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises

Non-platinum-based first-line followed by platinum-based second-line chemotherapy or the reverse sequence in patients with advanced non-small cell lung cancer: a retrospective analysis by the lung cancer group of the Hellenic Oncology Research Group

Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors

Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study

Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients.

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.

Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect

Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Third Harmonic Generation microscopy distinguishes malignant cell grade in human breast tissue biopsies

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer